AM Squared’s Idexx Laboratories IDXX Stock Holding History

AM Squared’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-100	Closed	-$48.7K	–	80
2024 Q2	$48.7K	Sell	100 -200	-67%	-$100K	0.12%	57
2024 Q1	$162K	Buy	+300	New	+$164K	0.4%	10

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AM Squared's IDXX Position: Q3 2024 in Review

AM Squared sold out of Idexx Laboratories (IDXX) in Q3 2024, closing a stake of 100 shares — an estimated $48.7K sold.

AM Squared first reported a position in IDXX in Q1 2024 and held it in 2 quarters. The position peaked at $162K in Q1 2024. 1,116 funds tracked by Wall St. Rank hold IDXX as of Q3 2024.

AM Squared reported no remaining Idexx Laboratories position as of Q3 2024 after selling out during the quarter.
AM Squared sold 100 Idexx Laboratories shares in Q3 2024, an estimated $48.7K.
AM Squared first reported a position in Idexx Laboratories in Q1 2024 and held it in 2 quarters.
AM Squared's Idexx Laboratories position peaked at $162K in Q1 2024.
1,116 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2024.

Based on AM Squared's 13F filing for Q3 2024, filed 7 Nov 2024.